 |
|
|
MassBiologics Deputy Director of Manufacturing Frank Fazio (center) leads a tour for local lawmakers of the MassBiologics SouthCoast facility. |
Chancellor Michael F. Collins and Mark S. Klempner, MD, executive vice chancellor for MassBiologics at UMass Medical School, provided a tour of the MassBiologics facility in Fall River on Monday, Sept. 18, to local lawmakers and discussed a promising gene therapy treatment underway, according to an article in the Standard Times.
The therapy, the first product to be manufactured in the Fall River lab, could improve quality of life for people with advanced Parkinson’s disease, Dr. Klempner said.
“We’re making the medicine in here, right now, for the big clinical trial that is going to go on in the next year,” Klempner is quoted in the Standard Times, adding that UMMS is collaborating with Voyager Therapeutics on the project.
Sen. Michael Rodrigues, D-Westport, hosted the event.
Read the full Standard Times story at: Fall River lab working on cutting-edge gene therapy
Related stories on UMassMedNow:
MassBiologics, Voyager Therapeutics announce collaboration for viral vector manufacturing
UMMS’ MassBiologics receives $5 million to fund viral vector manufacturing facility
